Dietary Enigmas
asking questions about our diet
-
Archive of "Nitric Oxide" Category
Fructose - Glucose - Sucrose = Villains?
Hi – if you are a regular reader of this blog you’ll know that one of my over riding themes is diabetes and poor understanding of the causes. Occasionally you get one of those ‘aha moments’ which just suggest further linkage. This article discusses the fructose-diabetes-High Fructose Corn Syrup-Sucrose linkage and surprisingly comes up with another item I’ve talked about Nitric Oxide (NO) and blood circulation. It would appear that NO and Diabetes are linked by the thread – Fructose leads to increased Uric Acid – high levels of Uric Acid – reduce Nitric Oxide levels – low levels of Nitric Oxide reduce the effectiveness of Insulin – and that leads to Insulin resistance and Metabolic Syndrome. OK – why is this interesting? I’ve just had a blood test with high levels of uric acid –in fact my Dr thinks it is why I’m getting some joint pain like Gout. I have been looking at ways of reducing the Uric acid levels by diet but never linked up all the above. Increase the NO levels in the blood by diet (see my article on NO and L-Arginnine), decrease the levels of high fructose corn syrup and decrease the amounts of glucose – see the article on Trehalose. Boy is this interesting. If you want an alternative to Glucose, Sucrose and Fructose - try Trehalose
This is so interesting I need to make a short video of the linkages.
Healthy Mentors - here to help you
Trehalose - the safe sugarJanuary 17, 2008
Fructose Called Most Dangerous Sugar
Corn syrup is Americans’ major dietary source; Findings add evidence to indictment of excess intake of all forms of sugar
by Craig WeatherbyApricot Kernels - B17 - benefits
I’ve recommended Apricot Kernels and other things as a source of B17 - wrongly called B17 as far as i can figure but that might be changing. Here is a great summary - if a little technical about B17 and what it does. We have seen some fascinating results with Sickle Cell Disease and B1, Apricot Kernels, Millet, and even Apricot Kernel Oil (cold pressed).
Apricot Kernels (B17 – called Vitamin B17 in error)
Apricot Kernels are the richest source of B17 (Laetrile). Ernst Krebs is the world’s leading authority on the relationship between cancer and nitrilosides, and the inventor of laetrile.
- G. Edward Griffin’s book World Without Cancer (American Media, 1974), available from Health World
- Ernst Krebs discussion of The Nature of Cancer
- Ernst Krebs discussion of the Trophoblast Theory of Cancer
- Ernst Krebs discussion of Trophoblasts and Morning Sickness
- Ernst Krebs discussion of the Metabolism of nitrilosides (Vitamin B17)
- Charles Gurchot’s explanation of How Vitamin B17 Works
Apricot kernels are known to prevent and cure cancer, even though the medical establishment has worked night and day and even lied to suppress it. B17 is found in most all fruit seeds such as the apple, peach, cherry, orange, nectarine and apricot. It is found in some beans and many grasses such as wheat grass. The hard wooden pit in the middle of the peach is not supposed to be thrown away. In fact, the wooden shell is strong armor protecting one of the most important foods known to man, the seed. It is one of the main courses of food in cultures such as the Navajo Indians, the Hunzas the Abkhasians and many more. Did you know that within these tribes there has never been a reported case of cancer. (And there are doctors and scientists from the
One of the most common nitrilosides is amygdalin. This nitriloside occurs in the kernels of seeds of practically all fruits. The seeds of apples, apricots, cherries, peaches, plums, nectarines, and the like carry this factor; often in the extraordinary concentration of 2 to 3 per cent. Since the seeds of fruits are possibly edible, it may be proper to designate the non-toxic water soluble accessory food factor or nitriloside that they contain as vitamin B-17. The presence of nitriloside in the diet produces specific physiologic effects and leaves as metabolites specific chemical compounds of a physiologically active nature. The production by a non-toxic, water-soluble accessory food factor of specific physiological effects as well as identifiable metabolites suggests the vitamin nature of the compound.
In metabolism, nitriloside is hydrolyzed to free hydrogen cyanide, benzaldehyde or acetone and sugar. This occurs largely through the enzyme Beta-glucosidase produced by intestinal bacteria as well as by the body. The released HCN [hydrocyanide] is detoxified by the enzyme rhodanese to the relatively non-toxic thiocyanate molecule. The sugar is normally metabolized. The released benzaldehyde in the presence of oxygen is immediately oxidized to benzoic acid which is non-toxic. Thus this newly designated vitamin B-17 (nitriloside) could account for:
- The thiocyanates in the body fluids–blood, urine, saliva, sweat, and tears;
- For part of the benzoic acid (and subsequently hippuric acid); salicylic acid isomers;
- For the HCN that goes to the production of cyanocobalamin from hydrocobalamin, or production of vitamin B12 from provitamin B12.
These are the physiological properties of the common nitriloside amygdalin. Before considering the possible antineoplastic activity of this vitamin B-17, let us recall that the benzoic acid arising from it has certain antirheumatic and antiseptic properties. It was rather widely used (in
Recall now, that thiocyanate also was once widely used, in both
Let us pause to reflect upon this question: Might not the rheumatic diseases as well as certain aspects of hypertension be in some cases partially related to a dietary deficiency in nitrilosides? One can hardly deny that the ingestion of a sufficient quantity of nitriloside-containing foods will metabolically yield sufficient benzoic acid and/or salicylic acid isomers to palliate rheumatic disease and certainly to decrease, however temporarily, hypertension as well as to foster the nitrilosation of provitamin B-12 to active vitamin B-12: cyanocobalamin.
Despite all this, are we justified in suggesting that cancer itself might be another chronic metabolic disease that arises from a specific vitamin deficiency–a deficiency specifically in B-17 (nitriloside)?
There are many chronic or metabolic diseases that challenge medicine. Many of these diseases have already been conquered. What proved to be their solution? By solution we mean both prevention and cure. What really cures really prevents. Let us think of some of these diseases that have found total prevention and hence cure. We are speaking of metabolic or non-transmissible diseases. At one time the metabolic disease known as scurvy killed hundreds of thousands of people, sometimes entire populations. This disease found total prevention and cure in the ascorbic acid or vitamin C component of fruits and vegetables. Similarly, the once fatal diseases so aptly called pernicious anaemia, pellagra, beri beri, countless neuropathies, and the like, found complete cure and prevention in specific dietary factors, that is, essential nutrients in an adequate diet.
Let’s go a step further, almost to the border of dogmatism, to advance an axiom in medicine and biology:
No chronic or metabolic disease has ever found cure or prevention, that is, real cure and real prevention–except through factors essential to an adequate diet and/or normal to animal economy.
I would welcome a contradiction to this principle; but even an exception would “prove the rule.”
Does it seem likely, therefore, that cancer will be the first exception to this generalization that to date has not had a single known exception? In my humble opinion, certainly not. But does it follow from this that B-17 (nitriloside) is the specific antineoplastic compound? Logically, by itself, alone, this conclusion that nitriloside is the specific antineoplastic compound does not follow. However, examine the brilliant laboratory studies of Dr. Dean Burk of the Department of Cytochemistry of the National Cancer Institute in
One might ask, then, whether we suggest that B-17 (nitriloside) or Laetrile is an effective cancer drug. Our reply must be: it is not a drug; it is a food.
REFERENCES
Baker, J.E., Rainey, D.P., Norris, D.M., and Strong, F.N., p-Hydroxybenzaldehyde and other Phenolics as Feeding Stimulants for the Smaller European Bark Bettle, Forest Sci., 14(1):91-95, 1968.
Blum, M.S., and Woodring, J.P., Secretion of Benzaldehyde and Hydrogen Cyanide by the Millipede Pachydemus crassicutus (Wood), Science, 158: 512-513, 1962.
Briese, R.R., and Couch, J.F., Preservation of Cyanogenetic Plants for Chemical Analysis, J.Agr.Research, 57(2): 81-107, 1937.
Brown, W.E., Wood, C.D., and Smith, A.N., Sodium Cyanide as a Cancer Chemotherapeutic Agent — Laboratory and Clinical Studies, Am.J.Obst. & Gynec., 80: 907-918, 1960.
Browne, J.G., Progress Report on the Work Done on the Hydrocyanic Acid Content of California Grown Lima Beans, Univ. Calif. Coll. of Agr., Agr. Exptl. Station, Project No. 521, p. 770 et seq., June 17, 1932.
Brioux, and Jones, E., The Production of Cyanogenetic Glycosides by Linseed: Measurement of HCN Production, Ann. Agron., 8(4): 468-480, 1932.
Chappel, C., Toxicity Studies on Amygdalin, McNaughton Foundation,
Charlton, J., The Selection of
Dedolph, R.R., and Hamilton, R.A., The Bitterness Problem in Some Seedling Macadamias (Due to amygdalin — ed.), Hawaii Farm. Sci., 8(1): 7-8, 1959.
Delga, J., Mizoula, J., Veverka, B., and Bon, R., Studies on the Treatment of Cyanide Intoxication by Hydroxycobalamin (Provitamin B-12), Ann. Pharmaceut., 19(12): 740-752, 1961.
Dillemann, G., Hydrocyanic Acid in Hybrids of the Pear with the Quince, Bull. Museum Natl. Hist. Nat., 18: 465-467, 1946.
Doak, B.W., Cyanoglucosides in White Clover, New Zealand J.Agr., 51: 159-162, 1935.
Domingues, J.B., Hydrocyanic Acid in Shoots of Dendrocalamus giganteus (Bamboo), An.Fac.Farm., E. Odontal Univ., Sao Paulo, 13: 169-171, 1955-1956.
Dunstan, W.R., Henry, T.A., and Auld, S.J.M., Cyanogenesis
IV. Occurrence of Phaseolunatin in Common Flax
V. Occurrence of Phaseolunatin in Cassava,Proc.Roy.Soc., 1906, 78B, 145-158.
Dunstan, W.R., and Henry, T.A., and Auld, S.J.M., Cyanogenesis in Plants
II. The Great Millet, Sorghum vulgare, Phil.Trans.Roy.Soc.,199A: 399-410, 1902.
Dunstan, W.R., Henry, T.A., and Auld, S.J.M., Cyanogenesis
VI. Phaseolunatin and the Associated Enzymes in Flax, Cassava, and the Lima Bean, Proc.Roy.Soc., 79B: 315-322, 1907.
Ekpechi, O.L., Dimitriadoo, A., and Fraser, R., Goitrogentic Activity of Cassava (A Staple Nigerian Food), Nature, 5041: 1137, June 11, 1966.
Festenstein, G.U., Substrates for Rumen Beta-Glucosidase, Biochem. J., 70(1): 49-51, 1958.
Flux, D.S., Butler, G.W., Johnson, J.M., Glenday, A.C., and Petersen, G.B., Goitrogenic Effects of White Clover, New Zealand J.of Sci. and Tech., 38(A): 88-102, 1956.
Flux, D.S.,
Golse, J., New Method for the Determination of Hydrocyanic Acid and Benzaldehyde in Cherry Brandy, J.Phar.Chim., 12:44-65, 1915.
Greshoff, M., The Distribution of Prussic Acid (HCN) in the Vegetable Kingdom, Report Brit.Assn., 138-144, 1906.
Guignard, L., The Development of Cyanogenetic Glucosides During the Germination of Plants, Compt.rend., 147: 1023-1038, 1908.
Guignard, L., The Presence of Cyanide-Yielding Compounds in the Elderberry, Compt.rend., 141: 16-20, 1905.
Herissey, H., The Cyanogenetic Glycoside Prulsurasin Crystallized from the Leaves of the Cherry Laurel, Compt.rend., 141: 959-961, 1905.
James, M.B., Fleming, J.W., and Bailey, L.F., Cyanide as a Growth-Inhibiting Substance in Extracts of Peach Leaves, Proc.Amer.Soc.Hort. Sci., 69: 152-157, 1957.
Jones, M.B., Seasonal Trend of Cyanide in Peach Leaves and Flower Buds and Its Possible Relation to the Rest Period.Proc. amer.Soc.Hort.Sci., 77: 117-120, 1961.[nee Jones?, rsc]
Liebig, J., and Wohler, F., The Composition of Bitter Almonds,Annalen, 22(1): 1-24, 1837.
Liebig, J., and Wohler, F., Formation of the Oil of Bitter Almonds, Ann.Chim.Phys., 64: 185-209, 1837.
Luh, B.S., and Pinochet, M.F., Spectrophotometric Determination of Hydrogen Cyanide in Canned Apricots, Cherries and Prunes, Food Research, 24: 423-427, 1950.
Martin, J.H., Couch, J.F., and Briese, R.R., Hydrocyanic Acid Content of Different Parts of the Sorghum Plant, Jour.Amer.Soc.Agron., 30(9): 725-734, 1938.
Michajlovski, M., Stukovsky, R., and Nemeth, S., Effects of Feed Composition on the Thiocyanate Content of Cow Milk, Biologica(Broteslavia), 16: 459-468, 1961.
Monekosso, G.L., and
McIlroy, “The Plant Glycosides,” Edward Arnold & Co.,
Oke, O.L., Chemical Studies of Some Nigerian Vegetables, Exp.Agr., 1(2): 125-129, 1965.
Osborne, D., Solving the Riddle of Wetherhill Mesa, Natl.Geo.Mag., 125(2): 155-194, 1964.
Perry, I.H., The Effect of Prolonged Cyanide Treatment on Body and Tumor Growth in Rats, Am.J.Cancer, 25: 592-[ff.],1935.
Pobiondek-Eabini, R., The Hydrogen Cyanide Content of Millet, Arch.Tiernarh., 2/3, 71-80, 1951.
Pjoan, M., Cyanide Poisoning from Choke
Rabati, J., Biochical Study of the Peach Tree, The Presence of Amygdonitrile Glucoside, Bull.Soc.Chim.Biol., 15: 385-395, 1933.
Schroder, J., and Damman, H., Studies of the Amount of Hydrocyanic Acid Obtained from Different Millets, Chem.Ztg., 35: 1436-7 (Chem.Abst. 62 1327).
Stebbins, R.C., Lizards Killed by Millipede (Through HCN-benzaldehyde emission from latter, ed.), Amer.Midland Nat., 32(3); 771-778, 1944.
Weiss, M., Hydrocyanic Acid in Apple Embryos, Flora, 149(3): 386-395, 1960.
Wokes, F., and Willimott, S.G., The Determination of Cyanide in Seeds, J.Pharm. & Pharmacol., 3: 905-917, 1951.
Worth, F.J., A Note on the Hydrocyanic Acid Content inNitric Oxide - and Health
With our work on Sickle Cell Disease over the last few months we’ve been trialling a compound that is known to produce Nitric Oxide. the initial results we’ve seen are very encouraging - like reducing sickle cell crisis pain to manageable levels within 15 minutes. This article is one that was one i came across today which supports the view that NO or Nitric Oxide is very helpful in a number of health issues.
If you’d like to know what compound we are using and where to get it please e mail me paul@sugars4life.com
Nitric oxide:From menace to marvel of the decade
A briefing document prepared for the Royal Society and Association of British Science Writers
Pearce Wright
May 1996Nitric oxide: From menace to marvel of the decade
Summary Research papers continue to flood the scientific journals with insights into the biological activity and potential clinical uses of nitric oxide (NO): a gas controlling a seemingly limitless range of functions in the body. Each revelation adds to nitric oxide’s already lengthy resume in controlling the circulation of the blood, and regulating activities of the brain, lungs, liver, kidneys, stomach, gut, genitals and other organs.
The molecule governs blood pressure, through a recently recognised process that contradicts textbook wisdom. It causes penile erections by dilating blood vessels, and controls the action of almost every orifice from swallowing to defecation. The immune system uses nitric oxide in fighting viral, bacterial and parasitic infections, and tumours. Nitric oxide transmits messages between nerve cells and is associated with the processes of learning, memory, sleeping, feeling pain, and, probably, depression. It is a mediator in inflammation and rheumatism.
Clinically, newborn babies with breathing problems are getting relief by an experimental inhalation treatment developed from this new understanding. A novel class of drugs that block the production of nitric oxide is being assessed as a possible treatment for septic shock. Drugs that liberate or enhance the action of nitric oxide may be useful in the treatment of pulmonary hypertension, and could prevent the formation of blood clots and counteract impotence. Animal experiments show how to manipulate nitric oxide production to stop the development of arthritis and kidney disease.
In the longer term, drugs that alter the amount or activity of nitric oxide might help protect the brain in conditions such as stroke, Alzheimers and Parkinsons disease. (more…)
- G. Edward Griffin’s book World Without Cancer (American Media, 1974), available from Health World